AZTR Projected Dividend Yield
Azitra Inc ( AMEX : AZTR )Azitra is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and topical live biotherapeutic products. Co.'s initial focus is on the development of its product candidates, including ATR-12, a genetically modified strain of S. epidermidis for treating the orphan disease, Netherton syndrom; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients; as well as ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris. 20 YEAR PERFORMANCE RESULTS |
AZTR Dividend History Detail AZTR Dividend News AZTR Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |